Riskpilot← Back to searchSign inGet full accessNOVODERMA AB
ABActiveOrg 5592207095Gränsgatan 24Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20192 employees
Revenue 2024
SEK 3,6M
-39% vs 2023
EBITDA margin
4.4%
-90% vs 2023
Equity ratio
41.5%
Financial strength
Net profit 2024
SEK 126K
-90% vs 2023
| Revenue | SEK 3,6M | -39% |
| EBITDA | SEK 160K | -90% |
| Net profit | SEK 126K | -90% |
| Total assets | SEK 3,6M | +46% |
| Equity | SEK 1,5M | -12% |
| Employees | 2 | — |
Legal name
NOVODERMA AB
Org number
5592207095
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
1 oktober 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Inköp och försäljning av kosmetiska produkter och klinisk utrustning. Import och export av kosmetiska och estetiska produkter inom EU och utanför EU. Utbildning av skönhetsbehandlingar, presentationer och workshop av kosmetiska och skönhetsprodukter.
Address
Gränsgatan 24
Email
suzanshammas01@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 3 964 | 5 230 | 5 973 | 3 619 |
| Staff expenses | — | — | −652 | −790 | −776 |
| EBITDA | — | 224 | 394 | 1 624 | 160 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 0 | 224 | 394 | 1 624 | 160 |
| Net financials | — | — | −1 | −1 | −61 |
| Profit before tax | 0 | 165 | 275 | 1 623 | 159 |
| Tax | −0 | −36 | −56 | −333 | −32 |
| Net profit | 0 | 129 | 219 | 1 290 | 126 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 690 | 1 361 | 2 460 | 3 590 |
| Equity | 50 | 179 | 397 | 1 687 | 1 490 |
| Long-term debt | 0 | 50 | 50 | 52 | 921 |
| Short-term debt | 0 | 403 | 737 | 544 | 655 |
| Total debt | — | 453 | 787 | 596 | 1 576 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
41.5%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20202024
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20202024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2024 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NOVODERMA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Georgina Ilia | Deputy Board Member | 0 companies |
| Farnoush Farasat | Deputy Board Member | 0 companies |
| Suzy Suzan Shammas | Board of Directors | 0 companies |
| Melinda Hanna | Deputy Board Member | 0 companies |